An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis

RecruitingOBSERVATIONAL

Enrollment

5,621

Participants

Timeline

Start Date

March 27, 2023

Primary Completion Date

August 15, 2027

Study Completion Date

August 15, 2028

Conditions

Pregnancy RelatedAtopic Dermatitis

Interventions

DRUG

Ruxolitinib Cream

DRUG

TCS

Topical corticosteroid

Trial Locations (1)

RECRUITING

Syneos Health (remote site), Morrisville